Actively Recruiting
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-12-07
2618
Participants Needed
1
Research Sites
311 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
J
Jinhua Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
CONDITIONS
Official Title
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Successful PCI with at least two of the following high-risk factors: left main lesion; bifurcation lesion (true bifurcation); ostial lesion of main vessels (left anterior descending, left circumflex artery, right coronary artery); chronic total occlusion; multivessel revascularization (2 or more vessels); in-stent restenosis; diffuse long lesion (lesion length 30 mm or more or stent length 38 mm or more); severe calcified lesion (significant severe calcification on angiography); bypass graft lesion; diabetes mellitus; chronic kidney disease (estimated glomerular filtration rate less than 30 ml/min/1.73 m2 or dialysis); myocardial infarction
- Provides written informed consent (self or legally authorized representative)
You will not qualify if you...
- Revascularization with bare metal stents and/or balloon angioplasty with non-drug-coated balloons
- Pregnant and/or lactating women
- Life expectancy of less than 2 years
- Planned repeat interventional therapy
- Unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
J
Jun Jiang, MD, PhD
CONTACT
J
Jinlong Zhang, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here